SynthesisBMC cancer2026

Association between ALK tyrosine kinase inhibitor and the risk of interstitial lung disease and pneumonitis in non-small cell lung cancer patients: a systematic review.

Shuimei Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.